Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Review of Vaccines|December 18, 2010
Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and YBrian Cooper, Lisa DeTora, Jeffrey Stoddard
Current Medical Research and Opinion|April 17, 2018
Substantial contribution and accountability: best authorship practices for medical writers in biomedical publicationsAngela Stocks, Donna Simcoe, Dikran Toroser, et al.
Biologicals : Journal of the International Association of Biological Standardization|July 1, 2011
Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applicationsMichael Bröker, Paolo Costantino, Lisa DeTora, et al.
Human Vaccines & Immunotherapeutics|April 18, 2012
Increase of meningococcal serogroup Y cases in Europe: a reason for concern?Michael Bröker, Susanne Jacobsson, Lisa DeTora, et al.
International Journal of Clinical Practice|February 9, 2018
Publication ethics from the ground upLisa DeTora, Cate Foster, Mukund Nori, et al.
Postgraduate Medicine|August 28, 2015
The sunshine act and medical publications: Guidance from professional medical associationsDikran Toroser, Lisa DeTora, Angela Cairns, et al.
Vaccine|January 11, 2012
The challenge of post-implementation surveillance for novel meningococcal vaccinesMatthew D Snape, Duccio Medini, Scott A Halperin, et al.
Human Vaccines|July 8, 2011
Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adultsDaniela Toneatto, Philipp Oster, A Corine W deBoer, et al.
Journal of Clinical Pharmacology|June 24, 2003
Characterization of etoricoxib, a novel, selective COX-2 inhibitorAimee Dallob, Christopher J Hawkey, Howard Greenberg, et al.
Pageof 1